Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer

Recruiting
18 years - 100 years
Male
1 Location

Brief description of study

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer.

Detailed description of study

Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Prostate Carcinoma,Prostate Cancer
  • Age: 18 years - 100 years
  • Gender: Male

Inclusion Criteria

Recently diagnosed with prostate cancer for whom definitive surgical treatment is indicated

Exclusion Criteria

Not suitable to undergo MRI or receive gadolinium-based contrast agent (severe, untreatable claustrophobia; MRI-incompatible metallic objects or implanted medical devices; renal failure; weight greater than allowable by scanner per institutional standard practice)

Prior surgical and/or non-surgical treatment for prostate cancer

Prior hip replacement or other major pelvic surgery

Updated on 04 Aug 2024. Study ID: 1902624997 (RADY-ECOG-ACRIN-EA8171)

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team